CD62L- Memory T Cells Enhance T-cell Regeneration After Allogeneic Stem Cell Transplantation by Eliminating Host Resistance in Mice

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2012 May 19

PMID 22596261

Citations 12

Authors

Jifeng Zhang

Brice E Barefoot

Wenjian Mo

Divino Deoliveira

Jessica Son

Xiuyu Cui

Elizabeth Ramsburg

Benny J Chen

Affiliations

Soon will be listed here.

Abstract

A major challenge in allogeneic hematopoietic cell transplantation is how to transfer T-cell immunity without causing graft-versus-host disease (GVHD). Effector memory T cells (CD62L(-)) are a cell subset that can potentially address this challenge because they do not induce GVHD. Here, we investigated how CD62L(-) T cells contributed to phenotypic and functional T-cell reconstitution after transplantation. On transfer into allogeneic recipients, CD62L(-) T cells were activated and expressed multiple cytokines and cytotoxic molecules. CD62L(-) T cells were able to deplete host radioresistant T cells and facilitate hematopoietic engraftment, resulting in enhanced de novo T-cell regeneration. Enhanced functional immune reconstitution was demonstrated in CD62L(-) T-cell recipients using a tumor and an influenza virus challenge model. Even though CD62L(-) T cells are able to respond to alloantigens and deplete host radioresistant immune cells in GVHD recipients, alloreactive CD62L(-) T cells lost the reactivity over time and were eventually tolerant to alloantigens as a result of prolonged antigen exposure, suggesting a mechanism by which CD62L(-) T cells were able to eliminate host resistance without causing GVHD. These data further highlight the unique characteristics of CD62L(-) T cells and their potential applications in clinical hematopoietic cell transplantation.

Citing Articles

Exploring the relationship between gut microbiota, immune characteristics, and female genital tract polyps using genetic evidence.

Jia R, Fu Y, Xue M, Zhou C, Jin J Medicine (Baltimore). 2024; 103(49):e40833.

PMID: 39654186 PMC: 11630997. DOI: 10.1097/MD.0000000000040833.

Insight on immune cells in rejection and infection postlung transplant.

Liao M, Wang C, Zhang M, Qiao K Immun Inflamm Dis. 2023; 11(7):e868.

PMID: 37506156 PMC: 10336664. DOI: 10.1002/iid3.868.

Controversies and expectations for the prevention of GVHD: A biological and clinical perspective.

Watkins B, Williams K Front Immunol. 2022; 13:1057694.

PMID: 36505500 PMC: 9726707. DOI: 10.3389/fimmu.2022.1057694.

A novel and efficient method to induce allospecific CD8 memory T lymphocytes.

Yang L, Huang Q, Fu J, Lin Z, Mao Q, Zhao L J Clin Lab Anal. 2021; 35(10):e23972.

PMID: 34465008 PMC: 8529130. DOI: 10.1002/jcla.23972.

Fluvastatin-Pretreated Donor Cells Attenuated Murine aGVHD by Balancing Effector T Cell Distribution and Function under the Regulation of KLF2.

Zhao K, Tian Y, Wang J, Chen C, Pan B, Yan Z Biomed Res Int. 2021; 2020:7619849.

PMID: 33415155 PMC: 7769635. DOI: 10.1155/2020/7619849.

References

Slavin S, Strober S . Spontaneous murine B-cell leukaemia. Nature. 1978; 272(5654):624-6. DOI: 10.1038/272624a0. View

Monteiro J, Benjamin A, Costa E, Barcinski M, Bonomo A . Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood. 2004; 105(4):1484-91. DOI: 10.1182/blood-2004-07-2856. View

Chen B, Cui X, Sempowski G, Domen J, Chao N . Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation. Blood. 2004; 103(11):4344-52. DOI: 10.1182/blood-2003-07-2534. View

Wysocki C, Panoskaltsis-Mortari A, Blazar B, Serody J . Leukocyte migration and graft-versus-host disease. Blood. 2005; 105(11):4191-9. PMC: 1895033. DOI: 10.1182/blood-2004-12-4726. View

Pelletier L, Bellon B, Druet P . [Cytokines and immune response]. Rev Prat. 1993; 43(5):536-46. View

Zhang Y, Joe G, Hexner E, Zhu J, Emerson S . Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med. 2005; 11(12):1299-305. DOI: 10.1038/nm1326. View

Martin P . Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans. J Exp Med. 1993; 178(2):703-12. PMC: 2191137. DOI: 10.1084/jem.178.2.703. View

Kreuwel H, Aung S, Silao C, Sherman L . Memory CD8(+) T cells undergo peripheral tolerance. Immunity. 2002; 17(1):73-81. DOI: 10.1016/s1074-7613(02)00337-0. View

Arber C, BitMansour A, Sparer T, Higgins J, Mocarski E, Weissman I . Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. Blood. 2003; 102(2):421-8. DOI: 10.1182/blood-2002-12-3834. View

10.

Spangrude G, Heimfeld S, Weissman I . Purification and characterization of mouse hematopoietic stem cells. Science. 1988; 241(4861):58-62. DOI: 10.1126/science.2898810. View

11.

Beilhack A, Schulz S, Baker J, Beilhack G, Wieland C, Herman E . In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005; 106(3):1113-22. PMC: 1895168. DOI: 10.1182/blood-2005-02-0509. View

12.

Gonzalez M, Quezada S, Blazar B, Panoskaltsis-Mortari A, Rudensky A, Noelle R . The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J Immunol. 2002; 169(10):5581-9. DOI: 10.4049/jimmunol.169.10.5581. View

13.

Ogasawara K, Benjamin J, Takaki R, Phillips J, Lanier L . Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol. 2005; 6(9):938-45. PMC: 1351289. DOI: 10.1038/ni1236. View

14.

Spickett G, Brandon M, Mason D, Williams A, Woollett G . MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen. J Exp Med. 1983; 158(3):795-810. PMC: 2187095. DOI: 10.1084/jem.158.3.795. View

15.

Chen B, Cui X, Sempowski G, Liu C, Chao N . Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood. 2003; 103(4):1534-41. DOI: 10.1182/blood-2003-08-2987. View

16.

Krenger W, Hill G, Ferrara J . Cytokine cascades in acute graft-versus-host disease. Transplantation. 1997; 64(4):553-8. DOI: 10.1097/00007890-199708270-00001. View

17.

Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401(6754):708-12. DOI: 10.1038/44385. View

18.

Kaech S, Hemby S, Kersh E, Ahmed R . Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 2003; 111(6):837-51. DOI: 10.1016/s0092-8674(02)01139-x. View

19.

Dutt S, Baker J, Kohrt H, Kambham N, Sanyal M, Negrin R . CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. Blood. 2011; 117(11):3230-9. PMC: 3062320. DOI: 10.1182/blood-2010-10-312751. View

20.

Huang X, Yang Y . The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation. Immunology. 2006; 118(3):361-71. PMC: 1782300. DOI: 10.1111/j.1365-2567.2006.02381.x. View